SCHEMBL4824976

SCHEMBL4824976

CCc1cccc(CC)c1-c1cc(OC(C)C)c(COc2cc(C)ccc2C(C)=O)c(C)n1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.41
C5AR1 P21730 3/20 0.38
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
FFAR4 Q5NUL3 2/20 0.35
FFAR1 O14842 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35
PDE5A O76074 4/20 0.35
ABCB1 P08183 2/20 0.34
LTB4R Q15722 1/20 0.34
S1PR1 P21453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1327355 0.93 AKR1C3 (0.40) AKR1C3C5AR1IDO1TDO2FFAR4
SCHEMBL1328853 0.92 AKR1C3 (0.42) AKR1C3C5AR1IDO1TDO2FFAR4
SCHEMBL1328812 0.91 AKR1C3 (0.45) AKR1C3C5AR1IDO1TDO2ALDH1A1
SCHEMBL4824163 0.91 AKR1C3 (0.43) AKR1C3C5AR1MAPTL3MBTL1ALDH1A1
SCHEMBL1327872 0.88 C5AR1 (0.39) AKR1C3C5AR1FFAR4FFAR1MAPT
SCHEMBL1327245 0.88 SCN9A (0.39) AKR1C3C5AR1HTTSMN1; SMN2L3MBTL1
SCHEMBL1329312 0.87 C5AR1 (0.40) AKR1C3C5AR1FFAR4FFAR1S1PR1
SCHEMBL1328955 0.86 C5AR1 (0.37) AKR1C3C5AR1FFAR4FFAR1LMNA
SCHEMBL1327952 0.86 KDM4E (0.41) C5AR1FFAR4FFAR1MAPTSMN1; SMN2
SCHEMBL1327830 0.86 MAPT (0.39) C5AR1LMNAMAPTHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342115-B2 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology NEUROGEN CORPORATION (US) 2008-03-11 US claimed
US-7342115-B2 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology NEUROGEN CORPORATION (US) 2008-03-11 US disclosed